8-KThe WireRoutine
Reg FD Disclosure
Filed Mar 10, 2026 · 3mo ago · Accession 0001628280-26-016516
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Vanda Pharmaceuticals Inc.
- Ticker
- VNDA
- CIK
- 1347178
- Form type
- 8-K
- Filing date
- Mar 10, 2026
- Report date
- Mar 10, 2026
- Document
- vnda-20260310.htm
- Size
- 143 KB